Slide 1: CARDIOLOGY NURSING Slide 2: THE CARDIOVASCULAR SYSTEM HEARTS NORMAL ANATOMY The heart is located in the LEFT

side of the mediastinum Consists of Three layers - epicardium, myocardium and endocardium Slide 3: THE CARDIOVASCULAR SYSTEM The epicardium covers the outer surface of the heart The myocardium is the middle muscular layer of the heart The endocardium lines the chambers and the valves Slide 4: THE CARDIOVASCULAR SYSTEM The layer that covers the heart is the PERICARDIUM There are two parts - parietal and visceral pericardium The space between the two pericardial layers is the pericardial space Slide 5: THE CARDIOVASCULAR SYSTEM The heart also has four chambers - two atria and two ventricles The Left atrium and the right atrium The left ventricle and the right ventricle Slide 6: The Cardiovascular System The heart chambers are guarded by valves The atrioventricular valves - tricuspid and bicuspid The semi-lunar valves - pulmonic and aortic valves Slide 7: The Cardiovascular System The Blood supply of the heart comes from the Coronary arteries 1. Right coronary artery supplies the RIGHT atrium and RIGHT ventricle, inferior portion of the LEFT ventricle, the POSTERIOR septal wall and the two nodes - AV (90%) and SA node (55%) Slide 8: The Cardiovascular System 2. Left coronary artery- branches into the LAD and the circumflex branch The LAD supplies blood to the anterior wall of the LEFT ventricle, the anterior septum and the Apex of the left ventricle The CIRCUMFLEX branch supplies the left atrium and the posterior LEFT ventricle Slide 10: The Cardiovascular System The CONDUCTING SYSTEM OF THE HEART Consists of the 1. SA node- the pacemaker 2. AV node- slowest conduction 3. Bundle of His branches into the Right and the Left bundle branch 4. Purkinje fibers- fastest conduction Slide 12: The Cardiovascular System The Heart sounds 1. S1- due to closure of the AV valves 2. S2- due to the closure of the semi-lunar valves 3. S3- due to increased ventricular filling 4. S4- due to forceful atrial contraction Slide 13: The Cardiovascular System Heart rate Normal range is 60-100 beats per minute Tachycardia is greater than 100 bpm Bradycardia is less than 60 bpm Sympathetic system INCREASES HR Parasympathetic system (Vagus) DECREASES HR Slide 14: The Cardiovascular System Blood pressure Cardiac output X peripheral resistance Control is neural (central and peripheral) and hormonal Baroreceptors in the carotid and aorta Hormones- ADH, aldosterone, epinephrine can increase BP; ANF can decrease BP

Slide 15: The Cardiovascular System The vascular system consists of the arteries, veins and capillaries The arteries are vessels that carry blood away from the heart to the periphery The veins are the vessels that carry blood to the heart The capillaries are lined with squamos cells, they connect the veins and arteries Slide 16: The Cardiovascular System The lymphatic system also is part of the vascular system and the function of this system is to collect the extravasated fluid from the tissues and returns it to the blood Slide 17: The Cardiovascular System Cardiac Assessment Slide 18: The Cardiovascular System Laboratory Test Rationale 1. To assist in diagnosing MI 2. To identify abnormalities 3. To assess inflammation Slide 19: The Cardiovascular System Laboratory Test Rationale 4. To determine baseline value 5. To monitor serum level of medications 6. To assess the effects of medications Slide 20: The Cardiovascular System LABORATORY PROCEDURES CARDIAC Proteins and enzymes CK- MB ( creatine kinase) Elevates in MI within 4 hours, peaks in 18 hours and then declines till 3 days Slide 21: The Cardiovascular System LABORATORY PROCEDURES CARDIAC Proteins and enzymes CK- MB ( creatine kinase) Normal value is 0-7 U/L Slide 22: The Cardiovascular System LABORATORY PROCEDURES CARDIAC Proteins and enzymes Lactic Dehydrogenase (LDH) Elevates in MI in 24 hours, peaks in 48-72 hours Normally LDH1 is greater than LDH2 Slide 23: The Cardiovascular System LABORATORY PROCEDURES CARDIAC Proteins and enzymes Lactic Dehydrogenase (LDH) MI- LDH2 greater than LDH1 (flipped LDH pattern) Normal value is 70-200 IU/L Slide 24: The Cardiovascular System LABORATORY PROCEDURES CARDIAC Proteins and enzymes Myoglobin Rises within 1-3 hours Peaks in 4-12 hours Returns to normal in a day Slide 25: The Cardiovascular System LABORATORY PROCEDURES CARDIAC Proteins and enzymes Myoglobin Not used alone Muscular and RENAL disease can have elevated myoglobin Slide 26: The Cardiovascular System LABORATORY PROCEDURES Troponin I and T Troponin I is usually utilized for MI Elevates within 3-4 hours, peaks in 4-24 hours and persists for 7 days to 3 weeks! Normal value for Troponin I is less than 0.6 ng/mL Slide 27: The Cardiovascular System LABORATORY PROCEDURES Troponin I and T

REMEMBER to AVOID IM injections before obtaining blood sample! Early and late diagnosis can be made! Slide 28: The Cardiovascular System LABORATORY PROCEDURES SERUM LIPIDS Lipid profile measures the serum cholesterol, triglycerides and lipoprotein levels Cholesterol= 200 mg/dL Triglycerides- 40- 150 mg/dL Slide 29: The Cardiovascular System LABORATORY PROCEDURES SERUM LIPIDS LDH- 130 mg/dL HDL- 30-70- mg/dL NPO post midnight (usually 12 hours) Slide 30: The Cardiovascular System LABORATORY PROCEDURES ELECTROCARDIOGRAM (ECG) A non-invasive procedure that evaluates the electrical activity of the heart Electrodes and wires are attached to the patient Slide 33: The Cardiovascular System LABORATORY PROCEDURES Holter Monitoring A noninvasive test in which the client wears a Holter monitor and an ECG tracing recorded continuously over a period of 24 hours Slide 34: The Cardiovascular System LABORATORY PROCEDURES Holter Monitoring Instruct the client to resume normal activities and maintain a diary of activities and any symptoms that may develop Slide 36: The Cardiovascular System LABORATORY PROCEDURES ECHOCARDIOGRAM Noninvasive test that studies the structural and functional changes of the heart with the use of ultrasound No special preparation is needed Slide 38: The Cardiovascular System LABORATORY PROCEDURES Stress Test A non-invasive test that studies the heart during activity and detects and evaluates CAD Exercise test, pharmacologic test and emotional test Slide 39: The Cardiovascular System LABORATORY PROCEDURES Stress Test Treadmill testing is the most commonly used stress test Used to determine CAD, Chest pain causes, drug effects and dysrhythmias in exercise Slide 40: The Cardiovascular System LABORATORY PROCEDURES Stress Test Pre-test: consent may be required, adequate rest , eat a light meal or fast for 4 hours and avoid smoking, alcohol and caffeine Slide 41: The Cardiovascular System LABORATORY PROCEDURES Post-test: instruct client to notify the physician if any chest pain, dizziness or shortness of breath . Instruct client to avoid taking a hot shower for 10-12 hours after the test Slide 42: The Cardiovascular System LABORATORY PROCEDURES Pharmacological stress test Use of dipyridamole Maximally dilates coronary artery Side-effect: flushing of face Slide 43: The Cardiovascular System LABORATORY PROCEDURES Pharmacological stress

test Pre-test: 4 hours fasting, avoid alcohol, caffeine Post test: report symptoms of chest pain Slide 44: The Cardiovascular System LABORATORY PROCEDURES CARDIAC catheterization Insertion of a catheter into the heart and surrounding vessels Determines the structure and performance of the heart valves and surrounding vessels Slide 45: The Cardiovascular System LABORATORY PROCEDURES CARDIAC catheterization Used to diagnose CAD, assess coronary atery patency and determine extent of atherosclerosis Slide 46: The Cardiovascular System LABORATORY PROCEDURES Pretest: Ensure Consent, assess for allergy to seafood and iodine, NPO, document weight and height, baseline VS, blood tests and document the peripheral pulses Slide 47: The Cardiovascular System LABORATORY PROCEDURES Pretest: Fast for 8-12 hours, teachings, medications to allay anxiety Slide 48: The Cardiovascular System LABORATORY PROCEDURES Intra-test: inform patient of a fluttery feeling as the catheter passes through the heart; inform the patient that a feeling of warmth and metallic taste may occur when dye is administered Slide 49: The Cardiovascular System LABORATORY PROCEDURES Post-test: Monitor VS and cardiac rhythm Monitor peripheral pulses, color and warmth and sensation of the extremity distal to insertion site Maintain sandbag to the insertion site if required to maintain pressure Monitor for bleeding and hematoma formation Slide 50: The Cardiovascular System LABORATORY PROCEDURES Maintain strict bed rest for 6-12 hours Client may turn from side to side but bed should not be elevated more than 30 degrees and legs always straight Encourage fluid intake to flush out the dye Immobilize the arm if the antecubital vein is used Monitor for dye allergy Slide 51: The Cardiovascular System LABORATORY PROCEDURES CVP The CVP is the pressure within the SVC Reflects the pressure under which blood is returned to the SVC and right atrium Slide 52: The Cardiovascular System LABORATORY PROCEDURES CVP Normal CVP is 0 to 8 mmHg/ 4-10 cm H2O Elevated CVP indicates increase in blood volume, excessive IVF or heart/renal failure Low CVP may indicated hypovolemia, hemorrhage and severe vasodilatation Slide 53: The Cardiovascular System LABORATORY PROCEDURES Measuring CVP 1. Position the client supine with bed elevated at 45 degrees 2. Position the zero point of the CVP line at the level of the right atrium. Usually this is at the MAL, 4th ICS 3. Instruct the client to be relaxed and avoid coughing and straining.

Slide 55: CARDIAC ASSESSMENT ASSESSMENT 1. Health History Obtain description of present illness and the chief complaint Chest pain, SOB, Edema, etc. Assess risk factors Slide 56: CARDIAC ASSESSMENT 2. Physical examination Vital signs- BP, PP, MAP Inspection of the skin Inspection of the thorax Palpation of the PMI, pulses Auscultation of the heart sounds Slide 58: CARDIAC ASSESSMENT 3. Laboratory and diagnostic studies CBC cardiac catheterization Lipid profile arteriography Cardiac enzymes and proteins CXR CVP EEG Holter monitoring Exercise ECG Slide 59: CARDIAC IMPLEMENTATION Assess the cardio-pulmonary status VS, BP, Cardiac assessment 2. Enhance cardiac output Establish IV line to administer fluids Slide 60: CARDIAC IMPLEMENTATION 3. Promote gas exchange Administer O2 Position client in SEMI-Fowlers Encourage coughing and deep breathing exercises Slide 61: CARDIAC IMPLEMENTATION 4. Increase client activity tolerance Balance rest and activity periods Assist in daily activities 5. Promote client comfort Assess the clients description of pain and chest discomfort Administer medication as prescribed Slide 62: CARDIAC IMPLEMENTATION 6. Promote adequate sleep 7. Prevent infection Monitor skin integrity of lower extremities Assess skin site for edema, redness and warmth Monitor for fever Change position frequently Slide 63: CARDIAC IMPLEMENTATION 8. Minimize patient anxiety Encourage verbalization of feelings, fears and concerns Answer client questions. Provide information about procedures and medications Slide 64: CARDIAC DISEASES Coronary Artery Disease Myocardial Infarction Congestive Heart Failure Infective Endocarditis Cardiac Tamponade Cardiogenic Shock Slide 65: VASCULAR DISEASES Hypertension Buergers disease Varicose veins Deep vein thrombosis Aneurysm Slide 66: CAD CAD results from the focal narrowing of the large and medium-sized coronary arteries due to deposition of atheromatous plaque in the vessel wall Slide 67: CAD RISK FACTORS 1. Age above 45/55 and Sex- Males and post-menopausal females 2. Family History 3. Hypertension 4. DM 5. Smoking 6. Obesity 7. Sedentary lifestyle 8. Hyperlipedimia Slide 68: CAD RISK FACTORS Most important MODIFIABLE factors: Smoking Hypertension Diabetes Cholesterol abnormalities Slide 69: CAD Pathophysiology Fatty streak formation in the vascular intima T-cells and

monocytes ingest lipids in the area of deposition atheroma narrowing of the arterial lumen reduced coronary blood flow myocardial ischemia Slide 70: CAD Pathophysiology There is decreased perfusion of myocardial tissue and inadequate myocardial oxygen supply If 50% of the left coronary arterial lumen is reduced or 75% of the other coronary artery, this becomes significant Potential for Thrombosis and embolism Slide 71: Angina Pectoris Chest pain resulting from coronary atherosclerosis or myocardial ischemia Slide 72: Angina Pectoris: Clinical Syndromes Three Common Types of ANGINA 1. STABLE ANGINA The typical angina that occurs during exertion, relieved by rest and drugs and the severity does not change Slide 73: Angina Pectoris: Clinical Syndromes Three Common Types of ANGINA 2. Unstable angina Occurs unpredictably during exertion and emotion, severity increases with time and pain may not be relieved by rest and drug Slide 74: Angina Pectoris: Clinical Syndromes Three Common Types of ANGINA 3. Variant angina Prinzmetal angina, results from coronary artery VASOSPASMS, may occur at rest Slide 75: Angina Pectoris ASSESSMENT FINDINGS 1. Chest pain- ANGINA The most characteristic symptom PAIN is described as mild to severe retrosternal pain, squeezing, tightness or burning sensation Radiates to the jaw and left arm Slide 76: Angina Pectoris ASSESSMENT FINDINGS 1. Chest pain- ANGINA Precipitated by Exercise, Eating heavy meals, Emotions like excitement and anxiety and Extremes of temperature Relieved by REST and Nitroglycerin Slide 77: Angina Pectoris ASSESSMENT FINDINGS 2. Diaphoresis 3. Nausea and vomiting 4. Cold clammy skin 5. Sense of apprehension and doom 6. Dizziness and syncope Slide 78: Angina Pectoris LABORATORY FINDINGS 1. ECG may show normal tracing if patient is pain-free. Ischemic changes may show ST depression and T wave inversion 2. Cardiac catheterization Provides the MOST DEFINITIVE source of diagnosis by showing the presence of the atherosclerotic lesions Slide 79: Angina Pectoris NURSING MANAGEMENT 1. Administer prescribed medications Nitrates- to dilate the coronary arteries Aspirin- to prevent thrombus formation Betablockers- to reduce BP and HR Calcium-channel blockers- to dilate coronary artery and reduce vasospasm Slide 80: 2. Teach the patient management of anginal attacks Advise patient to stop all activities Put one nitroglycerin tablet under the tongue Wait for 5 minutes If not relieved, take another tablet and wait for 5 minutes Another tablet can be taken (third tablet) If

unrelieved after THREE tablets seek medical attention Slide 81: Angina Pectoris 3. Obtain a 12-lead ECG 4. Promote myocardial perfusion Instruct patient to maintain bed rest Administer O2 @ 3 lpm Advise to avoid valsalva maneuvers Provide laxatives or high fiber diet to lessen constipation Encourage to avoid increased physical activities Slide 82: Angina Pectoris 5. Assist in possible treatment modalities PTCA- percutaneous transluminal coronary angioplasty To compress the plaque against the vessel wall, increasing the arterial lumen CABG- coronary artery bypass graft To improve the blood flow to the myocardial tissue Slide 84: Angina Pectoris 6. Provide information to family members to minimize anxiety and promote family cooperation 7. Assist client to identify risk factors that can be modified 8. Refer patient to proper agencies Slide 85: Myocardial infarction Death of myocardial tissue in regions of the heart with abrupt interruption of coronary blood supply Slide 87: Myocardial infarction ETIOLOGY and Risk factors 1. CAD 2. Coronary vasospasm 3. Coronary artery occlusion by embolus and thrombus 4. Conditions that decrease perfusionhemorrhage, shock Slide 88: Myocardial infarction Risk factors 1. Hypercholesterolemia 2. Smoking 3. Hypertension 4. Obesity 5. Stress 6. Sedentary lifestyle Slide 89: Myocardial infarction PATHOPHYSIOLOGY Interrupted coronary blood flow myocardial ischemia anaerobic myocardial metabolism for several hours myocardial death depressed cardiac function triggers autonomic nervous system response further imbalance of myocardial O2 demand and supply Slide 90: Myocardial infarction ASSESSMENT findings 1. CHEST PAIN Chest pain is described as severe, persistent, crushing substernal discomfort Radiates to the neck, arm, jaw and back Slide 91: Myocardial infarction ASSESSMENT findings 1. CHEST PAIN Occurs without cause, primarily early morning NOT relieved by rest or nitroglycerin Lasts 30 minutes or longer Slide 92: Myocardial infarction Assessment findings 2. Dyspnea 3. Diaphoresis 4. cold clammy skin 5. N/V 6. restlessness, sense of doom 7. tachycardia or bradycardia 8. hypotension 9. S3 and dysrhythmias Slide 93: Myocardial infarction Laboratory findings 1. ECG- the ST segment is ELEVATED. T wave inversion, presence of Q wave 2. Myocardial enzymes- elevated CK- MB, LDH and Troponin levels 3. CBC- may show elevated WBC count 4. Test after the acute stageExercise tolerance test, thallium scans, cardiac catheterization

Slide 95: Myocardial infarction Nursing Interventions 1. Provide Oxygen at 2 lpm, Semifowlers 2. Administer medications Morphine to relieve pain nitrates, thrombolytics, aspirin and anticoagulants Stool softener and hypolipidemics 3. Minimize patient anxiety Provide information as to procedures and drug therapy Slide 96: Myocardial infarction 4. Provide adequate rest periods 5. Minimize metabolic demands Provide soft diet Provide a low-sodium, low cholesterol and low fat diet 6. Minimize anxiety Reassure client and provide information as needed Slide 97: Myocardial infarction 7. Assist in treatment modalities such as PTCA and CABG 8. Monitor for complications of MI- especially dysrhythmias, since ventricular tachycardia can happen in the first few hours after MI 9. Provide client teaching Slide 99: MI Medical Management 1. ANALGESIC The choice is MORPHINE It reduces pain and anxiety Relaxes bronchioles to enhance oxygenation Slide 100: MI Medical Management 2. ACE Prevents formation of angiotensin II Limits the area of infarction Slide 101: MI Medical Management 3. Thrombolytics Streptokinase, Alteplase Dissolve clots in the coronary artery allowing blood to flow Slide 102: Myocardial infarction NURSING INTERVENTIONS AFTER ACUTE EPISODE 1. Maintain bed rest for the first 3 days 2. Provide passive ROM exercises 3. Progress with dangling of the feet at side of bed Slide 103: Myocardial infarction NURSING INTERVENTIONS AFTER ACUTE EPISODE 4. Proceed with sitting out of bed, on the chair for 30 minutes TID 5. Proceed with ambulation in the room toilet hallway TID Slide 104: Myocardial infarction NURSING INTERVENTIONS AFTER ACUTE EPISODE Cardiac rehabilitation To extend and improve quality of life Physical conditioning Patients who are able to walk 3-4 mph are usually ready to resume sexual activities Slide 105: CARDIOMYOPATHIES Heart muscle disease associated with cardiac dysfunction Slide 106: CARDIOMYOPATHIES 1. Dilated Cardiomyopathy 2. Hypertrophic Cardiomyopathy 3. Restrictive cardiomyopathy Slide 107: DILATED CARDIOMYOPATHY ASSOCIATED FACTORS 1. Heavy alcohol intake 2. Pregnancy 3. Viral infection 4. Idiopathic Slide 108: DILATED CARDIOMYOPATHY PATHOPHYSIOLOGY Diminished contractile proteins poor contraction decreased blood ejection increased blood remaining in the ventricle ventricular stretching and dilatation. SYSTOLIC DYSFUNCTION

Slide 109: HYPERTROPHIC CARDIOMYOPATHY Associated factors: 1. Genetic 2. Idiopathic Slide 110: HYPERTROPHIC CARDIOMYOPATHY Pathophysiology Increased size of myocardium reduced ventricular volume increased resistance to ventricular filling diastolic dysfunction Slide 111: RESTRICTIVE CARDIOMYOPATHY Associated factors 1. Infiltrative diseases like AMYLOIDOSIS 2. Idiopathic Slide 112: RESTRICTIVE CARDIOMYOPATHY Pathophysiology Rigid ventricular wall impaired stretch and diastolic filling decreased output Diastolic dysfunction Slide 113: CARDIOMYOPATHIES Assessment findings 1. PND 2. Orthopnea 3. Edema 4. Chest pain 5. Palpitations 6. dizziness 7. Syncope with exertion Slide 114: CARDIOMYOPATHIES Laboratory Findings 1. CXR- may reveal cardiomegaly 2. ECHOCARDIOGRAM 3. ECG 4. Myocardial Biopsy Slide 115: CARDIOMYOPATHIES Medical Management 1. Surgery 2. pacemaker insertion 3. Pharmacological drugs for symptom relief Slide 116: CARDIOMYOPATHIES Nursing Management 1.Improve cardiac output Adequate rest Oxygen therapy Low sodium diet Slide 117: CARDIOMYOPATHIES Nursing Management 2. Increase patient tolerance Schedule activities with rest periods in between Slide 118: CARDIOMYOPATHIES Nursing Management 3. Reduce patient anxiety Support Offer information about transplantations Support family in anticipatory grieving Slide 119: Infective endocarditis Infection of the heart valves and the endothelial surface of the heart Can be acute or chronic Slide 120: Infective endocarditis Etiologic factors 1. Bacteria- Organism depends on several factors 2. Fungi Slide 121: Infective endocarditis Risk factors 1. Prosthetic valves 2. Congenital malformation 3. Cardiomyopathy 4. IV drug users 5. Valvular dysfunctions Slide 122: Infective endocarditis Pathophysiology Direct invasion of microbes microbes adhere to damaged valve surface and proliferate damage attracts platelets causing clot formation erosion of valvular leaflets and vegetation can embolize Slide 123: Infective endocarditis Assessment findings 1. Intermittent HIGH fever 2. anorexia, weight loss 3. cough, back pain and joint pain 4. splinter hemorrhages under nails

Slide 124: Infective endocarditis Assessment findings 5. Oslers nodes- painful nodules on fingerpads 6. Roths spots- pale hemorrhages in the retina Slide 125: Infective endocarditis Assessment findings 7. Heart murmurs 8. Heart failure Slide 126: Infective endocarditis Prevention Antibiotic prophylaxis if patient is undergoing procedures like dental extractions, bronchoscopy, surgery, etc. Slide 127: Infective endocarditis LABORATORY EXAM Blood Cultures to determine the exact organism Slide 128: Infective endocarditis Nursing management 1. regular monitoring of temperature, heart sounds 2. manage infection 3. long-term antibiotic therapy Slide 129: Infective endocarditis Medical management 1. Pharmacotherapy IV antibiotic for 2-6 weeks Antifungal agents are given amphotericin B Slide 130: Infective endocarditis Medical management 2. Surgery Valvular replacement Slide 131: CHF A syndrome of congestion of both pulmonary and systemic circulation caused by inadequate cardiac function and inadequate cardiac output to meet the metabolic demands of tissues Slide 132: CHF Inability of the heart to pump sufficiently The heart is unable to maintain adequate circulation to meet the metabolic needs of the body Classified according to the major ventricular dysfunction- Left or Right Slide 134: CHF Etiology of CHF 1. CAD 2. Valvular heart diseases 3. Hypertension 4. MI 5. Cardiomyopathy 6. Lung diseases 7. Post-partum 8. Pericarditis and cardiac tamponade Slide 135: New York Heart Association Class 1 Ordinary physical activity does NOT cause chest pain and fatigue No pulmonary congestion Asymptomatic NO limitation of ADLs Slide 136: New York Heart Association Class 2 SLIGHT limitation of ADLs NO symptom at rest Symptom with INCREASED activity Basilar crackles and S3 Slide 137: New York Heart Association Class 3 Markedly limitation on ADLs Comfortable at rest BUT symptoms present in LESS than ordinary activity Slide 138: New York Heart Association Class 4 SYMPTOMS are present at rest Slide 139: CHF PATHOPHYSIOLOGY LEFT Ventricular pump failure back up of blood into the pulmonary veins increased pulmonary capillary pressure pulmonary congestion Slide 140: CHF PATHOPHYSIOLOGY LEFT ventricular failure decreased cardiac output

decreased perfusion to the brain, kidney and other tissues oliguria, dizziness Slide 141: CHF PATHOPHYSIOLOGY RIGHT ventricular failure blood pooling in the venous circulation increased hydrostatic pressure peripheral edema Slide 142: CHF PATHOPHYSIOLOGY RIGHT ventricular failure blood pooling venous congestion in the kidney, liver and GIT Slide 143: LEFT SIDED CHF ASSESSMENT FINDINGS 1. Dyspnea on exertion 2. PND 3. Orthopnea 4. Pulmonary crackles/rales 5. cough with Pinkish, frothy sputum 6. Tachycardia Slide 144: LEFT SIDED CHF ASSESSMENT FINDINGS 7. Cool extremities 8. Cyanosis 9. decreased peripheral pulses 10. Fatigue 11. Oliguria 12. signs of cerebral anoxia Slide 145: RIGHT SIDED CHF ASSESSMENT FINDINGS 1. Peripheral dependent, pitting edema 2. Weight gain 3. Distended neck vein 4. hepatomegaly 5. Ascites Slide 146: RIGHT SIDED CHF ASSESSMENT FINDINGS 6. Body weakness 7. Anorexia, nausea 8. Pulsus alternans Slide 147: CHF LABORATORY FINDINGS 1. CXR may reveal cardiomegaly 2. ECG may identify Cardiac hypertrophy 3. Echocardiogram may show hypokinetic heart Slide 148: CHF LABORATORY FINDINGS 4. ABG and Pulse oximetry may show decreased O2 saturation 5. PCWP is increased in LEFT sided CHF and CVP is increased in RIGHT sided CHF Slide 149: CHF NURSING INTERVENTIONS 1. Assess patient's cardio- pulmonary status 2. Assess VS, CVP and PCWP. Weigh patient daily to monitor fluid retention Slide 150: CHF NURSING INTERVENTIONS 3. Administer medications- usually cardiac glycosides are given- DIGOXIN or DIGITOXIN, Diuretics, vasodilators and hypolipidemics are prescribed Slide 151: CHF NURSING INTERVENTIONS 4. Provide a LOW sodium diet. Limit fluid intake as necessary 5. Provide adequate rest periods to prevent fatigue Slide 152: CHF NURSING INTERVENTIONS 6. Position on semi-fowlers to fowlers for adequate chest expansion 7. Prevent complications of immobility Slide 153: CHF NURSING INTERVENTION AFTER THE ACUTE STAGE 1. Provide opportunities for verbalization of feelings 2. Instruct the patient about the medication regimen- digitalis, vasodilators and diuretics 3. Instruct to avoid OTC drugs, Stimulants, smoking and alcohol Slide 154: CHF NURSING INTERVENTION AFTER THE ACUTE STAGE 4. Provide a LOW fat and LOW sodium diet 5. Provide potassium supplements 6. Instruct about fluid restriction

Slide 155: CHF NURSING INTERVENTION AFTER THE ACUTE STAGE 7. Provide adequate rest periods and schedule activities 8. Monitor daily weight and report signs of fluid retention Slide 156: CARDIOGENIC SHOCK Heart fails to pump adequately resulting to a decreased cardiac output and decreased tissue perfusion ETIOLOGY 1. Massive MI 2. Severe CHF 3. Cardiomyopathy 4. Cardiac trauma 5. Cardiac tamponade Slide 157: CARDIOGENIC SHOCK ASSESSMENT FINDINGS 1. HYPOTENSION 2. oliguria (less than 30 ml/hour) 3. tachycardia 4. narrow pulse pressure 5. weak peripheral pulses 6. cold clammy skin 7. changes in sensorium/LOC 8. pulmonary congestion Slide 158: CARDIOGENIC SHOCK LABORATORY FINDINGS Increased CVP Normal is 4-10 cmH2O Slide 159: CARDIOGENIC SHOCK NURSING INTERVENTIONS 1. Place patient in a modified Trendelenburg (shock ) position 2. Administer IVF, vasopressors and inotropics such as DOPAMINE and DOBUTAMINE 3. Administer O2 4. Morphine is administered to decreased pulmonary congestion and to relieve pain Slide 160: CARDIOGENIC SHOCK 5. Assist in intubation, mechanical ventilation, PTCA, CABG, insertion of Swan-Ganz cath and IABP 6. Monitor urinary output, BP and pulses 7. cautiously administer diuretics and nitrates Slide 161: CARDIAC TAMPONADE A condition where the heart is unable to pump blood due to accumulation of fluid in the pericardial sac (pericardial effusion) Slide 162: CARDIAC TAMPONADE This condition restricts ventricular filling resulting to decreased cardiac output Acute tamponade may happen when there is a sudden accumulation of more than 50 ml fluid in the pericardial sac Slide 163: CARDIAC TAMPONADE Causative factors 1. Cardiac trauma 2. Complication of Myocardial infarction 3. Pericarditis 4. Cancer metastasis Slide 164: CARDIAC TAMPONADE ASSESSMENT FINDINGS 1. BECKs Triad- Jugular vein distention, hypotension and distant/muffled heart sound 2. Pulsus paradoxus 3. Increased CVP 4. decreased cardiac output Slide 165: CARDIAC TAMPONADE ASSESSMENT FINDINGS 5. Syncope 6. anxiety 7. dyspnea 8. Percussion- Flatness across the anterior chest Slide 166: CARDIAC TAMPONADE Laboratory FINDINGS 1. Echocardiogram 2. Chest X-ray Slide 167: CARDIAC TAMPONADE NURSING INTERVENTIONS 1. Assist in PERICARDIOCENTESIS 2. Administer IVF 3. Monitor ECG, urine output and BP 4. Monitor for recurrence of tamponade

Slide 168: Pericardiocentesis Patient is monitored by ECG Maintain emergency equipments Elevate head of bed 45-60 degrees Monitor for complications- coronary artery rupture, dysrhythmias, pleural laceration and myocardial trauma Slide 169: HYPERTENSION A systolic BP greater than 140 mmHg and a diastolic pressure greater than 90 mmHg over a sustained period, based on two or more BP measurements. Slide 170: HYPERTENSION Types of Hypertension 1. Primary or ESSENTIAL Most common type 2. Secondary Due to other conditions like Pheochromocytoma, renovascular hypertension, Cushings, Conns , SIADH Slide 171: HYPERTENSION CLASSIFICATION OF HYPERTENSION by JNC- VII Slide 173: HYPERTENSION PATHOPHYSIOLOGY Multi-factorial etiology BP= CO (SV X HR) x TPR Any increase in the above parameters will increase BP 1. Increased sympathetic activity 2. Increased absorption of Sodium, and water in the kidney Slide 174: HYPERTENSION PATHOPHYSIOLOGY Multifactorial etiology BP= CO (SV X HR) x TPR Any increase in the above parameters will increase BP 3. Increased activity of the RAAS 4. Increased vasoconstriction of the peripheral vessels 5. insulin resistance Slide 175: HYPERTENSION ASSESSMENT FINDINGS 1. Headache 2. Visual changes 3. chest pain 4. dizziness 5. N/V Slide 176: HYPERTENSION Risk factors for Cardiovascular Problems in Hypertensive patients Major Risk factors 1. Smoking 2. Hyperlipidemia 3. DM 4. Age older than 60 5. GenderMale and post menopausal W 6. Family History Slide 177: HYPERTENSION DIAGNOSTIC STUDIES 1. Health history and PE 2. Routine laboratory- urinalysis, ECG, lipid profile, BUN, serum creatinine , FBS 3. Other lab- CXR, creatinine clearance, 24-huour urine protein Slide 178: HYPERTENSION MEDICAL MANAGEMENT 1. Lifestyle modification 2. Drug therapy 3. Diet therapy Slide 179: HYPERTENSION MEDICAL MANAGEMENT Drug therapy Diuretics Beta blockers Calcium channel blockers ACE inhibitors A2 Receptor blockers Vasodilators Slide 180: HYPERTENSION NURSING INTERVENTIONS 1. Provide health teaching to patient Teach about the disease process Elaborate on lifestyle changes Assist in meal planning to lose weight Slide 181: HYPERTENSION NURSING INTERVENTIONS 1. Provide health teaching to the patient Provide list of LOW fat , LOW sodium diet of less than 2-3 grams of Na/day Limit alcohol intake to 30 ml/day Regular aerobic exercise Advise to completely Stop smoking

Slide 182: HYPERTENSION Nursing Interventions 2. Provide information about antihypertensive drugs Instruct proper compliance and not abrupt cessation of drugs even if pt becomes asymptomatic/ improved condition Instruct to avoid over-the-counter drugs that may interfere with the current medication Slide 183: HYPERTENSION Nursing Intervention 3. Promote Home care management Instruct regular monitoring of BP Involve family members in care Instruct regular follow-up 4. Manage hypertensive emergency and urgency properly Slide 184: Vascular Diseases Slide 185: ANEURYSM Dilation involving an artery formed at a weak point in the vessel wall Slide 186: ANEURYSM Saccular= when one side of the vessel is affected Fusiform= when the entire segment becomes dilated Slide 187: ANEURYSM RISK FACTORS Atherosclerosis Infection= syphilis Connective tissue disorder Genetic disorder= Marfans Syndrome Slide 188: ANEURYSM PATHOPHYSIOLOGY Damage to the intima and media weakness outpouching Dissecting aneurysm tear in the intima and media with dissection of blood through the layers Slide 189: ANEURYSM ASSESSMENT Asymptomatic Pulsatile sensation on the abdomen Palpable bruit Slide 190: ANEURYSM LABORATORY: CT scan Ultrasound X-ray Aortography Slide 191: ANEURYSM Medical Management: Anti-hypertensives Synthetic graft Slide 192: ANEURYSM Nursing Management: Administer medications Emphasize the need to avoid increased abdominal pressure No deep abdominal palpation Remind patient the need for serial ultrasound to detect diameter changes Slide 193: PERIPHERAL ARTERIAL OCCLUSIVE DISEASE Refers to arterial insufficiency of the extremities usually secondary to peripheral atherosclerosis. Usually found in males age 50 and above The legs are most often affected Slide 194: PERIPHERAL ARTERIAL OCCLUSIVE DISEASE Risk factors for Peripheral Arterial occlusive disease Non-Modifiable 1. Age 2. gender 3. family predisposition Slide 195: PERIPHERAL ARTERIAL OCCLUSIVE DISEASE Risk factors for Peripheral Arterial occlusive disease Modifiable 1. Smoking 2. HPN 3. Obesity 4. Sedentary lifestyle 5. DM 6. Stress

Slide 196: PERIPHERAL ARTERIAL OCCLUSIVE DISEASE ASSESSMENT FINDINGS 1. INTERMITTENT CLAUDICATION- the hallmark of PAOD This is PAIN described as aching, cramping or fatiguing discomfort consistently reproduced with the same degree of exercise or activity Slide 197: PERIPHERAL ARTERIAL OCCLUSIVE DISEASE ASSESSMENT FINDINGS 1. INTERMITTENT CLAUDICATION- the hallmark of PAOD This pain is RELIEVED by REST This commonly affects the muscle group below the arterial occlusion Slide 198: PERIPHERAL ARTERIAL OCCLUSIVE DISEASE Assessment Findings 2. Progressive pain on the extremity as the disease advances 3. Sensation of cold and numbness of the extremities Slide 199: PERIPHERAL ARTERIAL OCCLUSIVE DISEASE Assessment Findings 4. Skin is pale when elevated and cyanotic/ruddy when placed on a dependent position 5. Muscle atrophy, leg ulceration and gangrene Slide 200: PERIPHERAL ARTERIAL OCCLUSIVE DISEASE Diagnostic Findings 1. Unequal pulses between the extremities 2. Duplex ultrasonography 3. Doppler flow studies Slide 201: PAOD Medical Management 1. Drug therapy Pentoxyfylline (Trental) reduces blood viscosity and improves supply of O2 blood to muscles Cilostazol (Pletaal) inhibits platelet aggregation and increases vasodilatation 2. Surgery- Bypass graft and anastomoses Slide 202: PERIPHERAL ARTERIAL OCCLUSIVE DISEASE Nursing Interventions 1. Maintain Circulation to the extremity Evaluate regularly peripheral pulses, temperature, sensation, motor function and capillary refill time Administer post-operative care to patient who underwent surgery Slide 203: PERIPHERAL ARTERIAL OCCLUSIVE DISEASE Nursing Interventions 2. Monitor and manage complications Note for bleeding, hematoma, decreased urine output Elevate the legs to diminish edema Encourage exercise of the extremity while on bed Teach patient to avoid leg-crossing Slide 204: PERIPHERAL ARTERIAL OCCLUSIVE DISEASE Nursing Interventions 3. Promote Home management Encourage lifestyle changes Instruct to AVOID smoking Instruct to avoid leg crossing Slide 205: BUERGERS DISEASE Thromboangiitis obliterans A disease characterized by recurring inflammation of the medium and small arteries and veins of the lower extremities Occurs in MEN ages 20-35 RISK FACTOR: SMOKING! Slide 206: BUERGERS DISEASE PATHOPHYSIOLOGY Cause is UNKNOWN Probably an Autoimmune disease Inflammation of the arteries thrombus formation occlusion of the vessels

Slide 207: BUERGERS DISEASE ASSESSMENT FINDINGS 1. Leg PAIN Foot cramps in the arch (instep claudication) after exercise Relieved by rest Aggravated by smoking, emotional disturbance and cold chilling 2. Digital rest pain not changed by activity or rest Slide 208: BUERGERS DISEASE ASSESSMENT FINDINGS 3. Intense RUBOR (reddish-blue discoloration), progresses to CYANOSIS as disease advances 4. Paresthesia Slide 209: BUERGERS DISEASE Diagnostic Studies 1. Duplex ultrasonography 2. Contrast angiography Slide 210: BUERGERS DISEASE Nursing Interventions 1. Assist in the medical and surgical management Bypass graft amputation 2. Strongly advise to AVOID smoking 3. Manage complications appropriately Slide 211: Medical Management 1. Drug therapy Pentoxyfylline (Trental) reduces blood viscosity and improves supply of O2 blood to muscles Cilostazol (Pletaal) inhibits platelet aggregation and increases vasodilatation 2. Surgery- Bypass graft and anastomoses Slide 212: BUERGERS DISEASE Nursing Interventions Post-operative care: after amputation Elevate stump for the FIRST 24 HOURS to minimize edema and promote venous return Place patient on PRONE position after 24 hours Assess skin for bleeding and hematoma Wrap the extremity with elastic bandage Slide 213: RAYNAUDS DISEASE A form of intermittent arteriolar VASOCONSTRICTION that results in coldness, pain and pallor of the fingertips or toes Cause : UNKNOWN Most commonly affects WOMEN, 16- 40 years old Slide 214: RAYNAUDS DISEASE ASSESSMENT FINDINGS 1. Raynauds phenomenon A localized episode of vasoconstriction of the small arteries of the hands and feet that causes color and temperature changes Slide 215: RAYNAUDS DISEASE W-B-R Pallor- due to vasoconstriction, then Blue- due to pooling of Deoxygenated blood Red- due to exaggerated reflow/hyperemia Slide 216: RAYNAUDS DISEASE ASSESSMENT FINDINGS 2. tingling sensation 3. Burning pain on the hands and feet Slide 217: RAYNAUDS DISEASE Medical management Drug therapy with the use of CALCIUM channel blockers To prevent vasospasms Slide 218: RAYNAUDS DISEASE Nursing Interventions 1. instruct patient to avoid situations that may be stressful 2. instruct to avoid exposure to cold and remain indoors when the climate is cold 3. instruct to avoid all kinds of nicotine 4. instruct about safety. Careful handling of sharp objects Slide 219: Venous diseases

Slide 220: VARICOSE VEINS THESE are dilated veins usually in the lower extremities Slide 221: VARICOSE VEINS Predisposing Factors Pregnancy Prolonged standing or sitting Constipation (for hemorrhoids) Incompetent venous valves Slide 222: VARICOSE VEINS Pathophysiology Factors venous stasis increased hydrostatic pressure edema Slide 223: VARICOSE VEINS Assessment findings Tortuous superficial veins on the legs Leg pain and Heaviness Dependent edema Slide 224: VARICOSE VEINS Laboratory findings Venography Duplex scan pletysmography Slide 225: VARICOSE VEINS Medical management Pharmacological therapy Leg vein stripping Anti-embolic stockings Slide 226: VARICOSE VEINS Nursing management 1. Advise patient to elevate the legs 2. Caution patient to avoid prolonged standing or sitting Slide 227: VARICOSE VEINS Nursing management 3. Provide high-fiber foods to prevent constipation 4. Teach simple exercise to promote venous return Slide 228: VARICOSE VEINS Nursing management 5. Caution patient to avoid knee-length stockings and constrictive clothings Slide 229: VARICOSE VEINS Nursing management 6. Apply anti-embolic stockings as directed 7. Avoid massage on the affected area Slide 230: DVT- Deep Vein Thrombosis Inflammation of the deep veins of the lower extremities and the pelvic veins The inflammation results to formation of blood clots in the area Slide 231: DVT- Deep Vein Thrombosis Predisposing factors Prolonged immobility Varicosities Traumatic procedures Slide 232: DVT- Deep Vein Thrombosis Complication PULMONARY thromboembolism Slide 233: DVT- Deep Vein Thrombosis Assessment findings Leg tenderness Leg pain and edema Positive HOMANs SIGN Slide 234: DVT- Deep Vein Thrombosis Laboratory findings Venography Duplex scan Slide 235: DVT- Deep Vein Thrombosis Medical management Antiplatelets Anticoagulants Vein stripping and grafting Anti-embolic stockings

Slide 236: DVT- Deep Vein Thrombosis Nursing management 1. Provide measures to avoid prolonged immobility Repositioning Q2 Provide passive ROM Early ambulation Slide 237: DVT- Deep Vein Thrombosis Nursing management 2. Provide skin care to prevent the complication of leg ulcers 3. Provide anti-embolic stockings Slide 238: DVT- Deep Vein Thrombosis Nursing management 4. Administer anticoagulants as prescribed 5. Monitor for signs of pulmonary embolism Slide 240: Blood disorders Anemia Nutritional anemia Hemolytic anemia Aplastic anemia Sickle cell anemia Slide 241: ANEMIA A condition in which the hemoglobin concentration is lower than normal Slide 242: ANEMIA Three broad categories 1. Loss of RBC- occurs with bleeding 2. Decreased RBC production 3. Increased RBC destruction Slide 243: Hypoproliferative Anemia Iron Deficiency Anemia Results when the dietary intake of iron is inadequate to produce hemoglobin Slide 244: Hypoproliferative Anemia Iron Deficiency Anemia Etiologic Factors 1. Bleeding- the most common cause 2. Mal-absorption 3. Malnutrition 4. Alcoholism Slide 245: Hypoproliferative Anemia IronDeficiency Anemia Pathophysiology The body stores of iron decrease, leading to depletion of hemoglobin synthesis Slide 246: Hypoproliferative Anemia IronDeficiency Anemia Pathophysiology The oxygen carrying capacity of hemoglobin is reduced tissue hypoxia Slide 247: Hypoproliferative Anemia Iron Deficiency Anemia Assessment Findings 1. Pallor of the skin and mucous membrane 2. Weakness and fatigue 3. General malaise 4. Pica Slide 248: Hypoproliferative Anemia Iron Deficiency Anemia Assessment Findings 5. Brittle nails 6. Smooth and sore tongue 7. Angular cheilosis Slide 249: Hypoproliferative Anemia Iron Deficiency Anemia Laboratory findings 1. CBC- Low levels of Hct, Hgb and RBC count 2. low serum iron, low ferritin 3. Bone marrow aspiration- MOST definitive Slide 250: Hypoproliferative Anemia Iron Deficiency Anemia Medical management 1. Hematinics 2. Blood transfusion Slide 251: Hypoproliferative Anemia Iron Deficiency Anemia Nursing Management 1. Provide iron rich-foods Organ meats (liver) Beans Leafy green vegetables Raisins and molasses

Slide 252: Hypoproliferative Anemia Nursing Management 2. Administer iron Oral preparations tablets- Fe fumarate, sulfate and gluconate Advise to take iron ONE hour before meals Take it with vitamin C Continue taking it for several months Slide 253: Hypoproliferative Anemia Nursing Management 2. Administer iron Oral preparations- liquid It stains teeth Drink it with a straw Stool may turn blackish- dark in color Advise to eat high-fiber diet to counteract constipation Slide 254: Hypoproliferative Anemia Nursing Management 2. Administer iron IM preparation Administer DEEP IM using the Z- track method Avoid vigorous rubbing Can cause local pain and staining Slide 255: APLASTIC ANEMIA Acondition characterized by decreased number of RBC as well as WBC and platelets Slide 256: APLASTIC ANEMIA CAUSATIVE FACTORS 1. Environmental toxins- pesticides, benzene 2. Certain drugs- Chemotherapeutic agents, chloramphenicol, phenothiazines, Sulfonamides 3. Heavy metals 4. Radiation Slide 257: APLASTIC ANEMIA Pathophysiology Toxins cause a direct bone marrow depression acellualr bone marrow decreased production of blood elements Slide 258: APLASTIC ANEMIA ASSESSMENT FINDINGS 1. fatigue 2. pallor 3. dyspnea 4. bruising 5. splenomegaly 6. retinal hemorrhages Slide 259: APLASTIC ANEMIA LABORATORY FINDINGS 1. CBC- decreased blood cell numbers 2. Bone marrow aspiration confirms the anemia- hypoplastic or acellular marrow replaced by fats Slide 260: APLASTIC ANEMIA Medical Management 1. Bone marrow transplantation 2. Immunosupressant drugs 3. Rarely, steroids 4. Blood transfusion Slide 261: APLASTIC ANEMIA Nursing management 1. Assess for signs of bleeding and infection 2. Instruct to avoid exposure to offending agents Slide 262: Megaloblastic Anemias Anemias characterized by abnormally large RBC secondary to impaired DNA synthesis due to deficiency of Folic acid and/or vitamin B12 Slide 263: Megaloblastic Anemias Folic Acid deficiency Causative factors 1. Alcoholism 2. Mal-absorption 3. Diet deficient in uncooked vegetables Slide 264: Megaloblastic Anemias Pathophysiology of Folic acid deficiency Decreased folic acid impaired DNA synthesis in the bone marrow impaired RBC development, impaired nuclear maturation but CYTOplasmic maturation continues large size

Slide 265: Megaloblastic Anemias Vitamin B12 deficiency Causative factors 1. Strict vegetarian diet 2. Gastrointestinal malabsorption 3. Crohn's disease 4. gastrectomy Slide 266: Megaloblastic Anemias Vitamin B12 deficiency Pernicious Anemia Due to the absence of intrinsic factor secreted by the parietal cells Intrinsic factor binds with Vit. B12 to promote absorption Slide 267: Megaloblastic Anemias Assessment findings 1. weakness 2. fatigue 3. listless 4. neurologic manifestations are present only in Vit. B12 deficiency Slide 268: Megaloblastic Anemias Assessment findings Pernicious Anemia Beefy, red, swollen tongue Mild diarrhea Extreme pallor Paresthesias in the extremities Slide 269: Megaloblastic Anemias Laboratory findings 1. Peripheral blood smear- shows giant RBCs, WBCs with giant hypersegmented nuclei 2. Very high MCV 3. Schillings test 4. Intrinsic factor antibody test Slide 270: Megaloblastic Anemias Medical Management 1. Vitamin supplementation Folic acid 1 mg daily 2. Diet supplementation Vegetarians should have vitamin intake 3. Lifetime monthly injection of IM Vit B12 Slide 271: Megaloblastic Anemias Nursing Management 1. Monitor patient 2. Provide assistance in ambulation 3. Oral care for tongue sore 4. Explain the need for lifetime IM injection of vit B12 Slide 272: Hemolytic Anemia: Sickle Cell Asevere chronic incurable hemolytic anemia that results from heritance of the sickle hemoglobin gene. Slide 273: Hemolytic Anemia: Sickle Cell Causative factor Genetic inheritance of the sickle gene- HbS gene Slide 274: Hemolytic Anemia: Sickle Cell Pathophysiology Decreased O2, Cold, Vasoconstriction can precipitate sickling process Slide 275: Hemolytic Anemia: Sickle Cell Pathophysiology Factors cause defective hemoglobin to acquire a rigid, crystal-like C-shaped configuration Sickled RBCs will adhere to endothelium pile up and plug the vessels ischemia results pain, swelling and fever Slide 276: Hemolytic Anemia: Sickle Cell Assessment Findings 1. jaundice 2. enlarged skull and facial bones 3. tachycardia, murmurs and cardiomegaly Slide 277: Hemolytic Anemia: Sickle Cell Assessment Findings Primary sites of thrombotic occlusion: spleen, lungs and CNS Chest pain, dyspnea Slide 278: Hemolytic Anemia: Sickle Cell Assessment Findings 1. Sickle cell crises Results from tissue hypoxia and necrosis 2. Acute chest syndrome Manifested by a

rapidly falling hemoglobin level, tachycardia, fever and chest infiltrates in the CXR Slide 279: Hemolytic Anemia: Sickle Cell Medical Management 1. Bone marrow transplant 2. Hydroxyurea Increases the HbF 3. Long term RBC trnasfusion Slide 280: Hemolytic Anemia: Sickle Cell Nursing Management 1. manage the pain Support and elevate acutely inflamed joint Relaxation techniques analgesics Slide 281: Hemolytic Anemia: Sickle Cell Nursing Management 2. Prevent and manage infection Monitor status of patient Initiate prompt antibiotic therapy Slide 282: Hemolytic Anemia: Sickle Cell Nursing Management 3. Promote coping skills Provide accurate information Allow patient to verbalize her concerns about medication, prognosis and future pregnancy Slide 283: Hemolytic Anemia: Sickle Cell Nursing Management 4. Monitor and prevent potential complications Provide always adequate hydration Avoid cold, temperature that may cause vasoconstriction Slide 284: Hemolytic Anemia: Sickle Cell Nursing Management 4. Monitor and prevent potential complications Leg ulcer Aseptic technique Slide 285: Hemolytic Anemia: Sickle Cell Nursing Management 4. Monitor and prevent potential complications Priapism Sudden painful erection Instruct patient to empty bladder, then take a warm bath Slide 286: Polycythemia Refers to an INCREASE volume of RBCs The hematocrit is ELEVATED to more than 55% Clasified as Primary or Secondary Slide 287: Polycythemia POLYCYTHEMIA VERA Primary Polycythemia A proliferative disorder in which the myeloid stem cells become uncontrolled Slide 288: Polycythemia POLYCYTHEMIA VERA Causative factor unknown Slide 289: Polycythemia POLYCYTHEMIA VERA Pathophysiology The stem cells grow uncontrollably The bone marrow becomes HYPERcellular and all the blood cells are increased in number Slide 290: Polycythemia POLYCYTHEMIA VERA Pathophysiology The spleen resumes its function of hematopoiesis and enlarges Blood becomes thick and viscous causing sluggish circulation Slide 291: Polycythemia POLYCYTHEMIA VERA Pathophysiology Overtime, the bone marrow becomes fibrotic Slide 292: Polycythemia POLYCYTHEMIA VERA Assessment findings 1. Skin is ruddy 2.

Splenomegaly 3. headache 4. dizziness, blurred vision 5. Angina, dyspnea and thrombophlebitis Slide 293: Polycythemia POLYCYTHEMIA VERA Laboratory findings 1. CBC- shows elevated RBC mass 2. Normal oxygen saturation 3 Elevated WBC and Platelets Slide 294: Polycythemia POLYCYTHEMIA VERA Complications 1. Increased risk for thrombophlebitis, CVA and MI 2. Bleeding due to dysfunctional blood cells Slide 295: Polycythemia POLYCYTHEMIA VERA Medical Management 1. To reduce the high blood cell mass- PHLEBOTOMY 2. Allopurinol 3. Dipyridamole 4. Chemotherapy to suppress bone marrow Slide 296: Polycythemia Nursing Management 1. Primary role of the nurse is EDUCATOR 2. Regularly asses for the development of complications 3. Assist in weekly phlebotomy 4. Advise to avoid alcohol and aspirin 5. Advise tepid sponge bath or cool water to manage pruritus Slide 297: Leukemia Malignant disorders of blood forming cells characterized by UNCONTROLLED proliferation of WHITE BLOOD CELLS in the bone marrow- replacing marrow elements . The WBC can also proliferate in the liver, spleen and lymph nodes. Slide 298: Leukemia Theleukemias are named after the specific lines of blood cells afffected primarily Myeloid Lymphoid Monocytic Slide 299: Leukemia The leukemias are named also according to the maturation of cells ACUTE The cells are primarily immature CHRONIC The cells are primarily mature or diferentiated Slide 300: Leukemia ACUTE myelocytic leukemia ACUTE lymphocytic leukemia CHRONIC myelocytic leukemia CHRONIC lymphocytic leukemia Slide 301: Leukemia ETIOLOGIC FACTORS UNKNOWM Probably exposure to radiation Chemical agents Infectious agents Genetic Slide 302: Leukemia PATHOPHYSIOLOGY of ACUTE Leukemia Uncontrolled proliferation of immature cells suppresses bone marrow function severe anemia, thrombocytopenia and granulocytopenia Slide 303: Leukemia PATHOPHYSIOLOGY of CHRONIC Leukemia Uncontrolled proliferation of DIFFERENTIATED cells slow suppression of bone marrow function milder symptoms Slide 304: Leukemia ASSESSMENT FINDINGS ACUTE LEUKEMIA Pallor Fatigue Dyspnea Hemorrhages Organomegaly Headache vomiting Slide 305: Leukemia ASSESSMENT FINDINGS CHRONIC LEUKEMIA Less severe

symptoms organomegaly Slide 306: Leukemia LABORATORY FINDINGS Peripheral WBC count varies widely Bone marrow aspiration biopsy reveals a large percentage of immature cells- BLASTS Erythrocytes and platelets are decreased Slide 307: Leukemia Medical Management 2. Chemotherapy 3. Bone marrow transplantation Slide 308: Leukemia Nursing Management 1. Manage AND prevent infection Monitor temperature Assess for signs of infection Be alert if the neutrophil count drops below 1,000 cells/mm3 Slide 309: Leukemia Nursing Management 2. Maintain skin integrity 3. Provide pain relief 4. Provide information as to therapy- chemo and bone marrow transplantation